- How Many Diabetes Patients Know the Name of Hypoglycemic Agents They Are Taking?
-
Kwon OB, Yu JH, Kim KK, Kang HC, Youn BB
- KMID: 2294658
- J Korean Acad Fam Med.
- 2005 Aug;26(8):456-463.
BACKGROUND: Numerous diabetes patients do not know the name of hypoglycemic agents that they are taking, even though they have taken them for a long time. The aim of this... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Practice Guideline 2015: Oral Hypoglycemic Agents for Patients with Type 2 Diabetes
-
Ko SH
- KMID: 2328571
- J Korean Diabetes.
- 2016 Jun;17(2):83-87.
- doi: 10.4093/jkd.2016.17.2.83
The revised Clinical Practice Guideline (5th edition) for patients with diabetes was released in November 2015 by the Korean Diabetes Association. Strict glycemic control is emphasized for the prevention and... -
- CITED
-
- Close
- SHARE
-
- Close
- Oral Antidiabetic Agents in Patients with Chronic Kidney Disease
-
Hwang YC
- KMID: 2059850
- J Korean Diabetes.
- 2011 Dec;12(4):194-197.
- doi: 10.4093/jkd.2011.12.4.194
Diabetes mellitus is the leading cause of chronic kidney disease worldwide. At present, a variety of classes of oral hypoglycemic agents are available to improve glycemic control, including newer classes... -
- CITED
-
- Close
- SHARE
-
- Close
- Recent Advances in the Development of Antidiabetic Drugs
-
Lee TH
- KMID: 2172499
- Chonnam Med J.
- 1999 Mar;35(1):1-12.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Use of Oral Hypoglycemic Agents in Type 2 Diabetic Patients with Hepatic Dysfunction
-
Lee KY
- KMID: 2059849
- J Korean Diabetes.
- 2011 Dec;12(4):190-193.
- doi: 10.4093/jkd.2011.12.4.190
The prevalence of type 2 diabetes mellitus in the Korea has increased dramatically over the past decade. Clinicians can prescribe the following six currently available classes of oral hypoglycemic agents:... -
- CITED
-
- Close
- SHARE
-
- Close
- Severe Acidosis after Massive Metformin Overdose
-
Kim BI, Jung JH, Eo EK
- KMID: 2203498
- J Korean Soc Clin Toxicol.
- 2008 Jun;6(1):42-44.
Metformin which is an oral hypoglycemic agents, acts by enhancing insulin sensitivity, decreasing hepatic glucose production and increasing peripheral utilization of glucose. Deliberate self poisoning with oral hypoglycemic agents is... -
- CITED
-
- Close
- SHARE
-
- Close
- A Pregnant Woman with Type 2 Diabetes Unintentionally Exposed to Metformin and Voglibose until the Second Trimester of Pregnancy: A Case Report
-
Kim YU, Kwak JH, Yeo SH, Moon SS, Lee YS
- KMID: 2362987
- J Korean Diabetes.
- 2016 Dec;17(4):277-281.
- doi: 10.4093/jkd.2016.17.4.277
Use of oral hypoglycemic agents during pregnant women with type 2 diabetes is controversial due to safety issues. Recently, randomized controlled trials support short-term safety of glyburide and metformin for... -
- CITED
-
- Close
- SHARE
-
- Close
- Hypoglycemia Care
-
Shin U
- KMID: 2137271
- J Korean Diabetes.
- 2015 Jun;16(2):130-134.
- doi: 10.4093/jkd.2015.16.2.130
Hypoglycemia is one barrier in providing optimal glycemic control in diabetes patients, and ironically the risk factors for hypoglycemia tend to be higher in patients with poor glycemic control. Severe... -
- CITED
-
- Close
- SHARE
-
- Close
- Conservative treatment for atypical endometrial hyperplasia: what is the most effective therapeutic method?
-
Kim MK, Seong SJ
- KMID: 2130092
- J Gynecol Oncol.
- 2014 Jul;25(3):164-165.
- doi: 10.3802/jgo.2014.25.3.164
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- What Is the Effect of Metformin Combined to Chemotherapy in Stage IV Colorectal Cancer with Diabetes?
-
Jung JT
- KMID: 1773068
- Korean J Gastroenterol.
- 2012 Dec;60(6):343-344.
- doi: 10.4166/kjg.2012.60.6.343
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment Strategy for Diabetes with Cardiovascular Disease
-
Jang YM, Kim SK
- KMID: 2059851
- J Korean Diabetes.
- 2011 Dec;12(4):198-200.
- doi: 10.4093/jkd.2011.12.4.198
Individuals with diabetes mellitus are at 2- to 3-fold increased risk of cardiovascular disease relative to individuals without diabetes, and hypoglycemia is associated with increased cardiovascular mortality in diabetic patients.... -
- CITED
-
- Close
- SHARE
-
- Close
- Letter: Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study (Diabetes Metab J 2019;43:640–8)
-
Moon JS
- KMID: 2466513
- Diabetes Metab J.
- 2019 Dec;43(6):911-912.
- doi: 10.4093/dmj.2019.0207
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Monotherapy in Type 2 Diabetes Mellitus Patients 2017: A Position Statement of the Korean Diabetes Association
-
Rhee SY
- KMID: 2408653
- J Korean Diabetes.
- 2018 Mar;19(1):15-22.
- doi: 10.4093/jkd.2018.19.1.15
When starting initial medication in people with type 2 diabetes mellitus (T2DM), the appropriate drug should be selected considering characteristics of the patient, efficacy, side effects, and cost. It is... -
- CITED
-
- Close
- SHARE
-
- Close
- Glucose Lowering Effect of SGLT2 Inhibitors: A Review of Clinical Studies
-
Kim HJ
- KMID: 2173886
- J Korean Diabetes.
- 2014 Sep;15(3):146-150.
- doi: 10.4093/jkd.2014.15.3.146
There are numerous glucose lowering agents in clinical use for type 2 diabetic patients, yet most do not achieve glycemic targets. Recently, inhibitors of the sodium glucose cotransporter 2 (SGLT2)... -
- CITED
-
- Close
- SHARE
-
- Close
- Glycemic Control in Diabetic Patients with Diabetic Nephropathy
-
Noh J
- KMID: 2331622
- J Korean Diabetes.
- 2013 Mar;14(1):23-26.
Diabetes mellitus is a leading cause of kidney disease; nearly one-third of patients with diabetes develop nephropathy. Several trials assessed the effect of intensive glycemic control in diabetic patients and... -
- CITED
-
- Close
- SHARE
-
- Close
- Combination Therapy of Oral Hypoglycemic Agents in Patients with Type 2 Diabetes Mellitus
-
Moon MK
- KMID: 2408654
- J Korean Diabetes.
- 2018 Mar;19(1):23-30.
- doi: 10.4093/jkd.2018.19.1.23
The Korean Diabetes Association (KDA) recently updated the Clinical Practice Guidelines on antihyperglycemic agent therapy for adult patients with type 2 diabetes mellitus (T2DM). In combination therapy of oral hypoglycemic... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effects of Hypoglycemic Agents on Non-alcoholic Fatty Liver Disease: Focused on Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists
-
Jung CH, Mok JO
- KMID: 2452623
- J Obes Metab Syndr.
- 2019 Mar;28(1):18-29.
- doi: 10.7570/jomes.2019.28.1.18
The only known, effective intervention for non-alcoholic fatty liver disease (NAFLD) is weight loss, and there is no approved pharmacotherapy. Recently, new hypoglycemic agents, such as sodium-glucose cotransporter 2 (SGLT2)... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Insulinoma Associated with Type 2 Diabetes Mellitus
-
Yoo SS, Shim WS, Kim CH, Ha KC, Lye SM, Kim EJ, Kim SH, Hong SB, Nam M, Kim YS
- KMID: 2177565
- J Korean Diabetes Assoc.
- 2007 Nov;31(6):517-519.
- doi: 10.4093/jkda.2007.31.6.517
An insulinoma is an endocrine tumor of the pancreas derived from the beta cells with abnormal insulin secretion. An insulinoma is rare, the incidence being estimated at only four per... -
- CITED
-
- Close
- SHARE
-
- Close
- Pharmacotherapy of Diabetes Focused on Stroke
-
Lyu YS, Kim JH, Kim SY
- KMID: 2454786
- J Korean Neurol Assoc.
- 2019 Aug;37(3):235-250.
- doi: 10.17340/jkna.2019.3.1
Cardiovascular disease, including stroke, is one of the major causes of death in diabetes. Numerous studies have long suggested reducing macrovascular complication such as ischemic vascular disease through intensive glycemic... -
- CITED
-
- Close
- SHARE
-
- Close
- DPP-4 Inhibitors as a New Option for the Management of Type 2 Diabetes
-
Lee SA
- KMID: 2173921
- J Korean Diabetes.
- 2013 Sep;14(3):128-132.
- doi: 10.4093/jkd.2013.14.3.128
Dipeptidylpeptidase-4 (DPP-4) inhibitors are new glucose-lowering agents with mechanisms that differ from those of previous oral hypoglycemic agents (OHAs). DPP-4 inhibitors have shown a continuous glucose lowering effect (> 0.5%)... -
- CITED
-
- Close
- SHARE
-
- Close
